|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
T�ܰ�ϸ�� |
|
ϸ�������� |
|
������Ӧ |
| ��������������� | |
|
��ź�� |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
T�ܰ�ϸ����Ӵ��Գ�����Ӧ�о���չ
��ź��, ����
����ҽѧԺ��һ����ҽԺƤ���Բ���, 650032
�Ӵ��Գ�����ӦΪTϸ���ԽӴ�Ƥ����ԭ�������ijٷ��ͳ�����Ӧ,Tϸ��ͨ������ϸ�����Ӽ�𤸽���ӱ��ı�,Ǩ�����ֲ�Ƥ��,������ЧӦ�͵���˫�ع���.��������Tϸ��ļ��Ƥ����ص�𤸽���Ӻ�ϸ����������,�Լ��ڽӴ��Գ�����Ӧ��ЧӦ�Ժ͵�����Tϸ���������ϸ��������÷�Ӧ�Ĺ�ϵ.
[2] Tedder TF,Steeber DA,Chen A,et al.The selectins:vascular adhesion molecules.FASEB J,1995,9(10):866-873.
[3] Morales J,Homey B,Vicari AP,et al.CTACK,a skin-associated chemokine that preferentially attracts skin-homing memory T cells.Proc Natl Acad Sci U S A,1999,96(25):14470-14475.
[4] Pan J,Kunkel E J,Gosslar U,et al.A novel chemokine ligand forCCR10 and CCR3 expressed by epithelial cells in mucosal tissues.J Immunol,2000,165(6):2943-2949.
[5] Campbell JJ,Haraldsen G,Pan J,et al.The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells.Nature,1999,400(6746):776-780.
[6] Cole KE,Strick CA,Paradis TJ,et al.Interferon-inducible T cell alpha chemoattractant(I-TAC):a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.J Exp Med,1998,187(12):2009-2021.
[7] Albanesi C,Scarponi C,Sebastiani S,et al.IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.J Immunol,2000,165(3):1395-1402.
[8] Garioch J J,Mackie RM,Campbell I,et al.Keratinocyte expressionof intercellular adhesion molecule 1(ICAM-1)correlated with infiltration of lymphocyte function associated antigen 1(LFA-1)positive cells in evolving allergic contact dermatitis reactions.Histopathology,1991,19(4):351-354.
[9] Albanesi C,Cavani A,Girolomoni G.IL-17 is produced by nickelspecific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes:synergistic or antagonist effects with IFN-gamma and TNF-alpha.J Immunol,1999,162(1):494-502.
[10] Cavani A,Albanesi C,Traidl C,et al.Effector and regulatory T cells in allergic contact dermatitis.Trends Immtnol,2001,22(3):118-120.
[11] Viraben R,Aquilina C,Cambon L,et al.Allergic contact dermatitis in HIV-positive patients.Contact Dermatitis,1994,31(5):326-327.
[12] Ho DD,Cao Y,Zhu T,et al.Idiopathic CD4 + T-lymphocytopema immunodeficiency without evidence of HIV infection.N Engl J Med,1993,328(6):380-385.
[13] Cavani A,Mei D,Guerra E,et al.Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickelspecific T cell responses.Evidence for the presence of effector CD8 + and regulatory CD4 + T cells.J Invest Dermatol,1998,111(4):621-628.
[14] Shreedhar VK,Pride MW,Sun Y,et al Origin and characteristics of ultraviolet-B radiationdnduced suppressor T lymphocytes.J Immunol,1998,161(3):1327-1335.
[15] Schwarz A,Grabbe S,Mahnke K,et al.Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CD8 + rather than CD4 + T cells.J Invest Dermatol,1998,110(3):272-276.
[16] Gocinski BL,Tigelaar RE.et al.Roles of CD4 + and CD8 + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion.J Immunol,1990,144(11):4121-4128.
[17] Wang B,Fujisawa H,Zhuang L,et al.CD4 + Thl and CD8 + type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity.J Immunol,2000,165(12):6783-6790.
[18] Roncarolo MG,Levings MK,Traversari C.Differentiation of T regulatory cells by immature dendritic cells.J Exp Med,2001,193(2):F5-9.
[19] Cavani A,NasorriF,Prezzi C,et al.Human CD4 + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses.J Invest Dermatol,2000,114(2):295-302.
[20] Schwarz A,Beissert S,Grosse-Heitmeyer K,et al.Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance.J Immunol,2000,165(4):1824-1831.